Intestinal bacteria may fuel inflammation and worsen HIV disease

July 10, 2013, University of California, San Francisco

A new study of HIV infection by UC San Francisco researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless prematurely experience life-shortening chronic diseases.

These changes in may perpetuate initially triggered by the body's immune response to HIV, according to the study, reported online July 10 in the journal Science Translational Medicine.

In recent years, such has been proposed as a cause of the early onset of common found in HIV patients, who now can live for decades without immune system destruction and death due to infection, thanks to lifelong treatment with . Likewise, in the general population, ongoing inflammation has been linked in some studies to chronic conditions such as heart disease, dementia and obesity.

Studies have shown that inflammation is induced by HIV in both treated and untreated patients, and is associated with—and possibly causes—disease in both, according to Joseph M. McCune, MD, PhD, chief of the Division of Experimental Medicine at UCSF and a senior author of the study. McCune has been investigating the causes of chronic inflammation in HIV-infected patients and has treated patients with HIV for more than three decades.

"We want to understand what allows the virus to persist in patients who have HIV disease, even after treatment," he said. "In this study, we see that bacteria in the gut may play a role."

The study was initiated by Ivan Vujkovic-Cvijin, a graduate student working in McCune's lab in collaboration with Susan Lynch, PhD, an associate professor in the Division of Gastroenterology at UCSF and an expert on the human microbiome, the collection of microbes the live in and on the human body. Researchers estimate that humans have about ten times as many as , and earlier studies have demonstrated that some of the microbes found within the intestines are able to drive immune responses, Lynch said.

"We thought the gut microbiome might be different in HIV-infected individuals, and that the high degree of immune activation in the patients might be associated with and possibly due to the presence of specific members of the bacterial community," Lynch said.

Vujkovic-Cvijin identified in biopsied patient samples by tracking a gene that is distinct among different bacterial species. Working with co-first author, Richard Dunham, PhD, a UCSF postdoctoral fellow, he also tracked markers of inflammation in the blood.

The researchers compared seven untreated HIV patients, including six with active infection and one long-term patient who never developed AIDS; 18 HIV patients in whom ongoing drug treatment had reduced HIV in the blood to undetectable levels; and nine uninfected individuals matched for other health risks. The patients are part of a group being monitored through ongoing UCSF research led by UCSF Steven Deeks, MD, and Jeffrey Martin, MD, MPH, at San Francisco General Hospital and Trauma Center.

"We found that HIV-infected people have a very different gut microbiome than people who are uninfected," Vujkovic-Cvijin said. "In particular, infected people harbor more bacteria that can cause harmful inflammation, like Pseudomonas, Salmonella, E. coli, and Staphylococcus."

The degree to which normal bacterial communities in the colon were disrupted corresponded to the levels of an inflammatory molecule, IL-6, in the blood, and also to the production of an enzyme called indoleamine 2,3-dioxygenase. The enzyme can impair the gut's ability to function as a barrier, thereby allowing bacteria and molecules produced by bacteria to enter the body to fuel even more inflammation. Species of bacteria that can mimic the action of this enzyme also were more abundant in HIV-infected participants, Vujkovic-Cvijin found.

The researchers do not believe that there is a single bacterial species responsible for disrupting the integrity of the gut nor do they propose a specific probiotic bacterial treatment to restore a healthy gut. Nonetheless, Lynch said, manipulating microbial populations is a promising idea.

"It appears that changes in the microbiome perpetuate a vicious cycle that drives inflammation in HIV-infected patients," she said. "We are considering a restoration ecology approach to restore appropriate microbial colonization patterns and healthy functioning of the gut microbiome."

McCune believes that inflammation may also play a role in maintaining the persistence of HIV, even in those with no circulating virus in the bloodstream. "Our dream is to be able to make the virus go away, allowing HIV-infected people to lead longer lives without the need for life-long therapy," he said. "Perhaps restoring the microbiome to normal will be one strategy to make that happen."

Explore further: Could probiotics help HIV patients?

More information: "Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism," by I. Vujkovic-Cvijin et al. Science Translational Medicine, 2013.

Related Stories

Could probiotics help HIV patients?

January 16, 2013
Antiretroviral (ARV) drugs are the first line therapy for patients with HIV; however, ARV-treated, HIV-infected individuals still have a higher mortality rate than uninfected individuals. During the course of infection, HIV ...

Researchers find immune cells may play previously unrecognized role in inflammation in HIV/AIDS

May 29, 2013
(Medical Xpress)—Depleted numbers of a specific type of white blood cell in the immune systems of people infected with HIV/AIDS appear to be associated with increased levels of unchecked and often damaging inflammation ...

Researchers identify potential new HIV vaccine/therapy target

May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, ...

HIV no barrier to getting liver transplant, study finds

May 17, 2013
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV

June 26, 2012
An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.